Pangaea Oncology SA
MAD:PANG

Watchlist Manager
Pangaea Oncology SA Logo
Pangaea Oncology SA
MAD:PANG
Watchlist
Price: 1.68 EUR -1.18%
Market Cap: 57.8m EUR

Gross Margin
Pangaea Oncology SA

65.2%
Current
58%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
65.2%
=
Gross Profit
9.7m
/
Revenue
14.9m

Gross Margin Across Competitors

No Stocks Found

Pangaea Oncology SA
Glance View

Pangaea Oncology SA provides molecular diagnostics and research development services in the field of personalized cancer treatment. The company is headquartered in Barcelona, Barcelona and currently employs 50 full-time employees. The company went IPO on 2016-12-29. The firm focuses on the development of oncology treatments. The Company’s activities are divided into two business lines: Clinical care in the Dr. Rosell Oncology Institute (IOR) and Molecular diagnosis (Dx). The IOR division offers personalized medical services related to oncology area, such as diagnosis, laboratory testing and treatment, in a chain of hospitals in Catalonia, Spain. The Dx division is responsible for the development of diagnostic and in-vitro services, biomarkers, as well as targeted drugs for patients and pharmaceutical companies. Its diagnostic models include Liquid Biopsy and Multiplexing.

PANG Intrinsic Value
2.35 EUR
Undervaluation 29%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
65.2%
=
Gross Profit
9.7m
/
Revenue
14.9m
What is the Gross Margin of Pangaea Oncology SA?

Based on Pangaea Oncology SA's most recent financial statements, the company has Gross Margin of 65.2%.

Back to Top